EDMONTON, Feb. 8 /CNW/ - Biomira Inc. (Nasdaq: BIOM) (TSX: BRA) today announced the completion at the end of January of its financing totaling U.S. $16,070,000, with Rodman & Renshaw LLC of New York acting as exclusive placement agent. The financing announced on January 27, 2006 was fully subscribed. About Biomira Biomira is a biotechnology company specializing in the development of innovative therapeutic approaches to cancer management. Biomira's commitment to the treatment of cancer currently focuses on the development of synthetic vaccines and novel strategies for cancer immunotherapy.